The Committee consists of 20 members, including the Chair. In addition, the Committee includes three voting ex officio members (or designees), including the Director, CDC;
the Administrator, CMS; and the Commissioner, FDA. A nonvoting representative from AdvaMed serves as the industry liaison. The Designated Federal Official (DFO) or their designee
and the Executive Secretary are present at all meetings to ensure meetings are within applicable statutory, regulatory and HHS General Administration manual directives.